[ Price : $8.95]
FDA clears a Pryor Medical Devices 510(k) for the ER-REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) catheter fo...[ Price : $8.95]
FDAs Arthritis Advisory Committee votes 10 to 4 to recommend approval of AstraZenecas lesinurad oral tablets for treating hyperuri...[ Price : $8.95]
CDRH says a recent analysis of IDE pre-submissions showed that IDEs submitted after a pre-submission have a greater likelihood of ...[ Price : $8.95]
CDER Office of Medical Policy (OMP) acting director Jonathan Jarow leaves his post to join the Office of the Center Director due t...[ Price : $8.95]
A new FDA interim policy on drug compounding indicates that the agency does not intend to take an enforcement action under certain...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance: National Environmental Policy Act; Environmental Assessments for Tobacco Product...[ Price : $8.95]
FDA says a recently concluded drug safety review of a Novartis Parkinson's therapy, Stalevo, has found no clear evidence of an inc...[ Price : $8.95]
A new CDER policy document outlines the procedures in the Office of Biotechnology Products and the Office of Manufacturing Quality...